PTEN function: how normal cells control it and tumour cells lose it.

The PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumour suppressor is a PI (phosphoinositide) 3-phosphatase that may inhibit mobile proliferation, survival and progress by inactivating PI 3-kinase-dependent signalling. It additionally suppresses mobile motility via mechanisms which may be partially unbiased of phosphatase exercise.
PTEN is among the mostly misplaced tumour suppressors in human most cancers, and its deregulation can also be implicated in a number of different ailments. Right here we talk about current developments in our understanding of how the mobile exercise of PTEN is regulated, and the carefully associated query of how this exercise is misplaced in tumours.
Mobile PTEN perform seems to be regulated by controlling each the expression of the enzyme and likewise its exercise via mechanisms together with oxidation and phosphorylation-based management of non-substrate membrane binding. Subsequently mutation of PTEN in tumours disrupts not solely the catalytic perform of PTEN, but in addition its regulatory features.
Nonetheless, though mutation of PTEN is unusual in lots of human tumour sorts, lack of PTEN expression appears to be extra frequent. It’s presently unclear how these tumours lose PTEN expression within the absence of mutation, and whereas some information implicate different potential tumour suppressors and oncogenes on this course of, this space appears prone to be a key focus of future analysis.
PTEN function: how normal cells control it and tumour cells lose it.

The mitochondrial permeability transition pore and its involvement in cell dying and in illness pathogenesis.

Present analysis on the mitochondrial permeability transition pore (PTP) and its function in cell dying faces a paradox. Initially thought of as an in vitro artifact of little pathophysiological relevance, in recent times the PTP has obtained appreciable consideration as a possible mechanism for the execution of cell dying.
The current profitable use of PTP desensitizers in a number of illness paradigms leaves little doubt about its relevance in pathophysiology; and rising findings that hyperlink the PTP to key mobile signalling pathways are growing the curiosity on the pore as a pharmacological goal.
But, current genetic information have challenged in style views on the molecular nature of the PTP, and known as into query many early conclusions about its construction. Right here we evaluate fundamental ideas about PTP construction, perform and regulation inside the framework of intramobile dying signalling, and its function in illness pathogenesis.

Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.

The interferon (IFN)-induced mobile antiviral response is the primary line of protection towards viral an infection inside an animal host. As a way to set up a productive an infection, eukaryotic viruses should first overcome the IFN-induced blocks imposed on viral replication.
The double-stranded RNA-activated protein kinase (PKR) is a key element mediating the antiviral actions of IFN. This IFN-induced protein kinase can limit viral replication via its capability to phosphorylate the protein synthesis initiation issue eukaryotic initiation factor-2 alpha-subunit and scale back ranges of viral protein synthesis. Viruses, subsequently, should block the perform of PKR to be able to keep away from these deleterious antiviral results related to PKR exercise.
Certainly, many viruses have developed efficient measures to repress PKR exercise throughout an infection. This evaluate will focus totally on an summary of the completely different molecular mechanisms employed by these viruses to fulfill a typical objective: the inhibition of PKR perform, uncompromised viral protein synthesis, and unrestricted virus replication.
The previous few years have seen thrilling new advances on this space. Reasonably unexpectedly, this space of analysis has benefited from the usage of the yeast system to review PKR. Different current advances embody research on PKR regulation by the herpes simplex viruses and information from our laboratory on the medically vital hepatitis C viruses.
We speculate that IFN is ineffective as a therapeutic agent towards hepatitis C virus as a result of the virus can successfully repress PKR perform. Lastly, we are going to talk about briefly the longer term instructions of this PKR discipline.

Adrenomedullin, a multifunctional regulatory peptide.

Because the discovery of adrenomedullin in 1993 a number of hundred papers have been printed relating to the regulation of its secretion and the multiplicity of its actions. It has been proven to be an nearly ubiquitous peptide, with the variety of tissues and cell sorts synthesizing adrenomedullin far exceeding these that don’t.
In Part II of this paper we give a complete evaluate each of tissues and cell traces secreting adrenomedullin and of the mechanisms regulating gene expression. The information on circulating adrenomedullin, obtained with the assorted assays accessible, are additionally reviewed, and the illness states wherein plasma adrenomedullin is elevated are listed.
In Part III the pharmacology and biochemistry of adrenomedullin binding websites, each particular websites and calcitonin gene-related peptide (CGRP) receptors, are mentioned. Particularly, the putative adrenomedullin receptor clones and sign transduction pathways are described.
In Part IV the assorted actions of adrenomedullin are mentioned: its actions on mobile progress, the cardiovascular system, the central nervous system, and the endocrine system are all thought of. Lastly, in Part V, we take into account some unresolved points and suggest future areas for analysis.

International phenotypic characterization of micro organism.

The measure of the standard of a programs biology mannequin is how properly it could possibly reproduce and predict the behaviors of a organic system reminiscent of a microbial cell.
Lately, these fashions have been constructed up in layers, and every layer has been rising in sophistication and accuracy in parallel with a worldwide information set to problem and validate the fashions in predicting the content material or actions of genes (genomics), proteins (proteomics), metabolites (metabolomics), and in the end cell phenotypes (phenomics).
PTEN function: how normal cells control it and tumour cells lose it.
This evaluate focuses on the latter, the phenotypes of microbial cells. The event of Phenotype MicroArrays, which try to offer a worldwide view of mobile phenotypes, is described.

CD45RA

45RAPP2-100T 100 test
EUR 349

CD45RA

45RAPU1-01MG 0,1 mg
EUR 219

CD45RA

45RAPU2-01MG 0,1 mg
EUR 219

CD45RA Antigen (CD45RA/PTPRC) Antibody

abx413329-01mg 0.1 mg
EUR 453

CD45RA Antigen (CD45RA/PTPRC) Antibody

abx413626-2ml 2 ml
EUR 606

CD45RA Antigen (CD45RA/PTPRC) Antibody

abx414688-1mg 1 mg
EUR 829

CD45RA Antigen (CD45RA/PTPRC) Antibody

abx414689-01mg 0.1 mg
EUR 439

CD45RA Antigen (CD45RA/PTPRC) Antibody

abx414691-025mg 0.25 mg
EUR 565

CD45RA Antigen (CD45RA/PTPRC) Antibody

abx415596-02mg 0.2 mg
EUR 565

CD45RA Antigen (CD45RA/PTPRC) Antibody

abx415611-20ug 20 ug
EUR 272

CD45RA Antigen (CD45RA/PTPRC) Antibody (FITC)

abx413328-01mg 0.1 mg
EUR 648

CD45RA Antigen (CD45RA/PTPRC) Antibody (RPE)

abx413330-100tests 100 tests
EUR 718

CD45RA Antigen (CD45RA/PTPRC) Antibody (FITC)

abx414287-01mg 0.1 mg
EUR 509

CD45RA Antigen (CD45RA/PTPRC) Antibody (FITC)

abx414687-01mg 0.1 mg
EUR 509

CD45RA Antigen (CD45RA/PTPRC) Antibody (RPE)

abx414690-100tests 100 tests
EUR 592

CD45RA Antigen (CD45RA/PTPRC) Antibody (FITC)

abx415608-01mg 0.1 mg
EUR 509

CD45RA Antigen (CD45RA/PTPRC) Antibody (FITC)

abx415609-25ug 25 ug
EUR 272

CD45RA Antigen (CD45RA/PTPRC) Antibody (RPE)

abx415610-100tests 100 tests
EUR 592

CD45RA antibody

10-Z45R 800 ug
EUR 247
Description: Mouse monoclonal CD45RA antibody

CD45RA antibody

10R-6408 100 ug
EUR 208
Description: Mouse monoclonal CD45RA antibody

CD45RA Antibody

20-abx134010
  • EUR 356.00
  • EUR 565.00
  • EUR 300.00
  • 100 ul
  • 200 ul
  • 50 ul

CD45RA Antibody

abx200318-100ug 100 ug
EUR 328

CD45RA Antibody

abx200322-100ug 100 ug
EUR 328

CD45RA Antibody

abx139821-01mg 0.1 mg
EUR 356

CD45RA/CD4

45RAF24PE1-50T 50 test
EUR 364.6

CD4/CD45RA

4F45RAPE2-50T 50 test
EUR 521.9

CD45RA antibody (biotin)

61R-1507 100 ug
EUR 300
Description: Mouse monoclonal CD45RA antibody (biotin)

CD45RA antibody (allophycocyanin)

61R-1736 100 tests
EUR 457
Description: Mouse monoclonal CD45RA antibody (allophycocyanin)

CD45RA Antibody (Biotin)

abx133997-100Assays 100 Assays
EUR 439

CD45RA Antibody (Biotin)

abx133997-50Assays 50 Assays
EUR 342

CD45RA Antibody (FITC)

abx134000-100Assays 100 Assays
EUR 439

CD45RA Antibody (FITC)

abx134000-50Assays 50 Assays
EUR 342

CD45RA Antibody (PE)

abx134004-100Assays 100 Assays
EUR 439

CD45RA Antibody (PE)

abx134004-50Assays 50 Assays
EUR 342

CD45RA Antibody (FITC)

abx200319-100tests 100 tests
EUR 425

CD45RA Antibody (PE)

abx200320-100tests 100 tests
EUR 606

CD45RA Antibody (FITC)

abx200323-100tests 100 tests
EUR 398

CD45RA Antibody (PE)

abx200324-100tests 100 tests
EUR 453

CD45RA Antibody (APC)

abx200325-100tests 100 tests
EUR 453

CD45RA Antibody (PerCP)

abx200326-100tests 100 tests
EUR 453

CD45RA Antibody (Biotin)

abx200327-100ug 100 ug
EUR 384

CD45RA Antibody (PerCP)

abx139830-100tests 100 tests
EUR 481

CD45RA Antibody (PE)

abx139831-100tests 100 tests
EUR 481

CD45RA Antibody (APC)

abx139832-100tests 100 tests
EUR 481

CD45RA Antibody (Biotin)

abx139833-01mg 0.1 mg
EUR 425

CD45RA Antibody (FITC)

abx139834-100tests 100 tests
EUR 425

Anti-CD45RA antibody

STJ16100065 100 µg
EUR 406

Anti-CD45RA antibody

STJ180061 0.1 ml
EUR 212

pMD-19T-CD45RA Plasmid

PVTB00058 2 ug
EUR 356

Anti-Hu CD45RA PerCP

PC-223-T025 25 tests
EUR 140

Anti-Hu CD45RA PerCP

PC-223-T100 100 tests
EUR 240

Anti-Hu CD45RA APC

1A-223-T025 25 tests
EUR 140

Anti-Hu CD45RA APC

1A-223-T100 100 tests
EUR 240

Anti-Hu CD45RA Biotin

1B-223-C025 0.025 mg
EUR 122

Anti-Hu CD45RA Biotin

1B-223-C100 0.1 mg
EUR 204

Anti-Hu CD45RA FITC

1F-223-T025 25 tests
EUR 122

Anti-Hu CD45RA FITC

1F-223-T100 100 tests
EUR 204

Anti-Hu CD45RA PE

1P-223-T025 25 tests
EUR 140

Anti-Hu CD45RA PE

1P-223-T100 100 tests
EUR 240

CD45RA(158-4D3) Antibody

BNCA0028-250 250uL
EUR 383
Description: Primary antibody against CD45RA(158-4D3), APC conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNCA0818-250 250uL
EUR 383
Description: Primary antibody against CD45RA(PTPRC/818), APC conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNCA1038-250 250uL
EUR 383
Description: Primary antibody against CD45RA(111-1C5), APC conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCA1131-250 250uL
EUR 383
Description: Primary antibody against CD45RA(PTPRC/1131), APC conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCA1148-250 250uL
EUR 383
Description: Primary antibody against CD45RA(PTPRC/1148), APC conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNCAP0028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNCAP0028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNCAP0818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNCAP0818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC810028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC810028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC810818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC810818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC811038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC811038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC811131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC811131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC811148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC811148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), CF680R conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC880028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC880028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNCAP1038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNCAP1038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCAP1131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCAP1131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCAP1148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCAP1148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNCB0028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNCB0028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNCB0818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNCB0818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNCB1038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNCB1038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCB1131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCB1131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCB1148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCB1148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), Biotin conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC471038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC471038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC471131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC471131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC471148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC471148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC550028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC550028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC550818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC550818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC551038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC551038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC551131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC551131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC551148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC551148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), CF555 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC430818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC430818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC431038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC431038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC431131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC431131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC431148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC431148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), CF543 conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC470028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC470028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC470818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC470818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), CF647 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC880818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC880818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC881038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC881038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC881131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC881131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC881148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC881148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), CF488A conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC940028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC940028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC940818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC940818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC941038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC941038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC941131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC941131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC941148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC941148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), CF594 conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCH1131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCH1131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCH1148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCH1148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNCP0028-250 250uL
EUR 383
Description: Primary antibody against CD45RA(158-4D3), PerCP conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNCP0818-250 250uL
EUR 383
Description: Primary antibody against CD45RA(PTPRC/818), PerCP conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNCP1038-250 250uL
EUR 383
Description: Primary antibody against CD45RA(111-1C5), PerCP conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNCP1131-250 250uL
EUR 383
Description: Primary antibody against CD45RA(PTPRC/1131), PerCP conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNCP1148-250 250uL
EUR 383
Description: Primary antibody against CD45RA(PTPRC/1148), PerCP conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNCR0028-250 250uL
EUR 383
Description: Primary antibody against CD45RA(158-4D3), RPE conjugate, Concentration: 0.1mg/mL

Anti-Hu CD45RA Purified

11-223-C025 0.025 mg
EUR 99

Anti-Hu CD45RA Purified

11-223-C100 0.1 mg
EUR 158

CD45RA(158-4D3) Antibody

BNC040028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC040028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC040818-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/818), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/818) Antibody

BNC040818-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/818), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC041038-100 100uL
EUR 199
Description: Primary antibody against CD45RA(111-1C5), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(111-1C5) Antibody

BNC041038-500 500uL
EUR 544
Description: Primary antibody against CD45RA(111-1C5), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC041131-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1131), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1131) Antibody

BNC041131-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1131), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC041148-100 100uL
EUR 199
Description: Primary antibody against CD45RA(PTPRC/1148), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(PTPRC/1148) Antibody

BNC041148-500 500uL
EUR 544
Description: Primary antibody against CD45RA(PTPRC/1148), CF405S conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC050028-100 100uL
EUR 199
Description: Primary antibody against CD45RA(158-4D3), CF405M conjugate, Concentration: 0.1mg/mL

CD45RA(158-4D3) Antibody

BNC050028-500 500uL
EUR 544
Description: Primary antibody against CD45RA(158-4D3), CF405M conjugate, Concentration: 0.1mg/mL
Along with their use in fleshing out and validating programs biology fashions, there are lots of different makes use of of this international phenotyping know-how in fundamental and utilized microbiology analysis, that are additionally described.

Leave a Comment